Incannex Commences Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis Feb 28, 2023 | ASX News, Incannex Healthcare (ASX:IHL)
Confirmation of Capital Structure – CHESS Depositary Interests on Issue Jun 29, 2021 | ASX News, Nyrada Inc (ASX:NYR)
